MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
160 hedge funds and large institutions have $1.56B invested in Momenta Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 53 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
160
Holders Change
-3
Holders Change %
-1.84%
% of All Funds
3.67%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
18
Increased
60
Reduced
53
Closed
21
Calls
$2.62M
Puts
$969K
Net Calls
+$1.65M
Net Calls Change
-$520K
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$75.7M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$59.7M |
| 3 |
BlackRock
New York
|
+$18.9M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$18M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.24M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$104M |
| 2 |
Millennium Management
New York
|
-$12.1M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$9.08M |
| 4 |
JPMorgan Chase & Co
New York
|
-$6.32M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$4.8M |
